Gossamer Bio News

Gossamer Bio | 8-K: Current report

Mar 12 16:05 ET

Gossamer Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 5 07:42 ET

Gossamer Bio | 8-K: Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Mar 5 07:32 ET

Gossamer Bio | 8-K: Current report

Mar 4 16:06 ET

Gossamer Bio | 8-K: Current report

Nov 29, 2023 16:01 ET

Gossamer Bio | 8-K: Current report

Nov 27, 2023 16:01 ET

Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update

Nov 9, 2023 07:31 ET

Gossamer Bio | 8-K: Current report

Oct 20, 2023 16:01 ET

Gossamer Bio | 8-K: Current report

Sep 7, 2023 17:00 ET

Gossamer Bio | S-3: Registration statement for specified transactions by certain issuers

Aug 18, 2023 08:41 ET

Gossamer Bio | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Aug 17, 2023 16:01 ET

Gossamer Bio | 8-K: Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update

Aug 8, 2023 16:01 ET

Gossamer Bio | 8-K: Current report

Jul 20, 2023 16:01 ET

Gossamer Bio | 8-K: Current report

Jul 20, 2023 07:50 ET

Gossamer Bio | 8-K: Current report

Jun 9, 2023 16:14 ET

Gossamer Bio | DEFA14A: Others

May 9, 2023 16:04 ET

Gossamer Bio | 8-K: Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update

May 9, 2023 16:03 ET

Gossamer Bio | DEFA14A: Others

Apr 28, 2023 16:02 ET

Gossamer Bio | DEF 14A: Definitive proxy statements

Apr 28, 2023 16:01 ET

Gossamer Bio | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 17, 2023 16:01 ET